G T250 (Ticlopidine 250 mg)
Pill imprint G T250 has been identified as Ticlopidine 250 mg.
Ticlopidine is used in the treatment of cerebral thrombosis/embolism and belongs to the drug class platelet aggregation inhibitors. There is no proven risk in humans during pregnancy. Ticlopidine 250 mg is not subject to the Controlled Substances Act.
See also related documents.
Images for G T250 (Ticlopidine 250 mg)
- Imprint:
-
G
T250 - Strength:
- 250 mg
- Color:
- White
- Shape:
- Elliptical / Oval
- Availability:
- Prescription only
- Drug Class:
- Platelet aggregation inhibitors
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- N - Not a controlled drug
- Manufacturer:
- Par Pharmaceutical Inc.
- National Drug Code (NDC):
- 49884-0599
More resources
Ticlopidine is associated with the treatment of:
Search by Imprint, Shape or Color
Note: All fields are optional. Use the pill finder to identify medications by visual appearance or name. All Rx and OTC drugs in the US are required by the FDA to have an imprint. If your pill has no imprint it could be a vitamin, diet/herbal/energy pill, illicit or foreign drug. More about imprint codes...

